Knowledge about clinical trials is a barrier to participation, and minorities in general, are significantly underrepresented compared to non-Hispanic Whites. My primary goal as a researcher is to better understand the barriers to participation among minorities with hematologic malignancies by conducting a multi-institutional study that will build on the preliminary findings of my pilot study. My second equally important goal is to participate in global initiatives to increase minorities’ knowledge about cancer clinical trials.